All updated as on -
From 2024–2031, the travel vaccines market is expected to expand from an initial valuation of $3.22B in 2023 to an estimated $8.37B in 2031, a compound annual growth rate (CAGR) of 13.5%.
The predicted rise in travel-related illnesses is a key factor propelling the market forward. Health hazards, particularly those related to infectious diseases, tend to be higher when traveling. As a result, the worldwide Travel Vaccines Market will see increased investment as a result of the growing number of travel-related disorders. The research study offers a comprehensive analysis of the market for travel vaccines worldwide. The research provides an in-depth evaluation of the market's most important subsegments, trends, drivers, constraints, competitive landscape, and factors.
Tourists can avoid potentially deadly diseases by getting travel immunizations, often called "go vaccines," before visiting certain parts of the world. Vaccines against diseases that are common while travel protect against those diseases by exposing the body to the virus or bacteria that cause them. In order to defend itself from future exposure to the disease, the body produces antibodies in response to the vaccine. A vaccine is a bio-based medication that is mostly created to fortify the immune system of a patient against a specific disease. The vaccine's components are derived from the microbe's weakened or dead form and are identical to those found in the target organism.
Vaccine stain, vaccination schedule, disease pathophysiology, and genetic predisposition all play important roles in determining how effective vaccine formulations are. Vaccines are mixtures of either dead germs, attenuated living organisms, or fully pathogenic living organisms that are used to artificially boost or develop immunity for a particular disease. Emporiatrics is a branch of medicine concerned with the diagnosis and treatment of common medical problems experienced by international travelers. In order to travel responsibly and safely, one must first get the recommended immunizations. These days, no one can leave the country without first getting a passport and any necessary travel vaccinations.
Specialized immunizations called "travel vaccines" are advised for anyone planning to travel to areas with a higher risk of certain infectious diseases. Diseases that are common in the area the traveler plans to visit may not be common in their home nation, but these immunizations can protect them from them. Hepatitis A, B, influenza, meningococcal, diphtheria, pertussis, and tetanus (DPT) are just a few of the many diseases that can be protected against with a travel vaccine. Recombinant DNA technology and mRNA vaccines technology are two examples of modern vaccine development methods that have completely altered the vaccine creation process. The development of personalized vaccines that may be adjusted to target particular varieties or strains of infections has been made possible by breakthroughs in biotechnology. Due to the fact that disease incidence and strains might differ by place, this is especially crucial for travel vaccines.
The travel vaccinations sector was greatly affected by the COVID-19 pandemic. Worldwide panic over the COVID-19 pandemic, along with travel bans, lockdowns, and quarantines, caused domestic and international travel to drop sharply. The demand for travel vaccines was hit hard since many consumers decided to delay or cancel their vacation plans. Global tourism saw a 4% increase in 2021 compared to 2020 (415 million versus 400 million), according to a report issued in January 2023 by the World Tourism Organization (UNWTO). Nevertheless, according to preliminary estimates provided by UNWTO, international tourist visits in 2019 were still 72% lower than the year before the epidemic. The United Nations World Tourism Organization has declared 2020 to be the worst year for tourism ever, with a 73% drop in international tourists.
Changes in domestic regulation that affect present and future market trends are also detailed in the report's nation section, along with other market-impacting factors. Market forecasts for specific nations are based on a variety of data points, including analyses of the upstream and downstream value chains, case studies, technical trends, and Porter's Five Forces model. When making predictions based on national statistics, we also take into account things like the availability and presence of global brands, the difficulties encountered by these brands as a result of strong or weak competition from local and domestic brands, the effect of domestic tariffs, and trade routes.
Report Coverage
Global Travel Vaccines research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Travel Vaccines report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Travel Vaccines competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Travel Vaccines market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Travel Vaccines market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Travel Vaccines market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
GSK plc (U.K.), Sanofi (France), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Bavarian Nordic (Denmark), Janssen Pharmaceuticals Inc. (U.S.), CSL Limited (Australia), AstraZeneca (U.K.), Altimmune (U.K.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Crucell (Netherlands)
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Travel Vaccines market based on the below-mentioned segments:
Global Travel Vaccines Market, By Composition
Mono vaccines
Combination vaccines
Global Travel Vaccines market, By Application
Outbound travel
Domestic travel
Global Travel Vaccines Market, By Disease Type
Hepatitis A
Hepatitis B
Influenza
Diphtheria pertussis tetanus (DPT)
Rabies
Yellow fever
Typhoid
Measles and mumps
Meningococcal
Other disease vaccines
Global Travel Vaccines market, Regional Analysis
The predicted rise in travel-related illnesses is a key factor propelling the market forward. Health hazards, particularly those related to infectious diseases, tend to be higher when traveling. As a result, the worldwide Travel Vaccines Market will see increased investment as a result of the growing number of travel-related disorders. The research study offers a comprehensive analysis of the market for travel vaccines worldwide. The research provides an in-depth evaluation of the market's most important subsegments, trends, drivers, constraints, competitive landscape, and factors.
Tourists can avoid potentially deadly diseases by getting travel immunizations, often called "go vaccines," before visiting certain parts of the world. Vaccines against diseases that are common while travel protect against those diseases by exposing the body to the virus or bacteria that cause them. In order to defend itself from future exposure to the disease, the body produces antibodies in response to the vaccine. A vaccine is a bio-based medication that is mostly created to fortify the immune system of a patient against a specific disease. The vaccine's components are derived from the microbe's weakened or dead form and are identical to those found in the target organism.
Vaccine stain, vaccination schedule, disease pathophysiology, and genetic predisposition all play important roles in determining how effective vaccine formulations are. Vaccines are mixtures of either dead germs, attenuated living organisms, or fully pathogenic living organisms that are used to artificially boost or develop immunity for a particular disease. Emporiatrics is a branch of medicine concerned with the diagnosis and treatment of common medical problems experienced by international travelers. In order to travel responsibly and safely, one must first get the recommended immunizations. These days, no one can leave the country without first getting a passport and any necessary travel vaccinations.
Specialized immunizations called "travel vaccines" are advised for anyone planning to travel to areas with a higher risk of certain infectious diseases. Diseases that are common in the area the traveler plans to visit may not be common in their home nation, but these immunizations can protect them from them. Hepatitis A, B, influenza, meningococcal, diphtheria, pertussis, and tetanus (DPT) are just a few of the many diseases that can be protected against with a travel vaccine. Recombinant DNA technology and mRNA vaccines technology are two examples of modern vaccine development methods that have completely altered the vaccine creation process. The development of personalized vaccines that may be adjusted to target particular varieties or strains of infections has been made possible by breakthroughs in biotechnology. Due to the fact that disease incidence and strains might differ by place, this is especially crucial for travel vaccines.
The travel vaccinations sector was greatly affected by the COVID-19 pandemic. Worldwide panic over the COVID-19 pandemic, along with travel bans, lockdowns, and quarantines, caused domestic and international travel to drop sharply. The demand for travel vaccines was hit hard since many consumers decided to delay or cancel their vacation plans. Global tourism saw a 4% increase in 2021 compared to 2020 (415 million versus 400 million), according to a report issued in January 2023 by the World Tourism Organization (UNWTO). Nevertheless, according to preliminary estimates provided by UNWTO, international tourist visits in 2019 were still 72% lower than the year before the epidemic. The United Nations World Tourism Organization has declared 2020 to be the worst year for tourism ever, with a 73% drop in international tourists.
Changes in domestic regulation that affect present and future market trends are also detailed in the report's nation section, along with other market-impacting factors. Market forecasts for specific nations are based on a variety of data points, including analyses of the upstream and downstream value chains, case studies, technical trends, and Porter's Five Forces model. When making predictions based on national statistics, we also take into account things like the availability and presence of global brands, the difficulties encountered by these brands as a result of strong or weak competition from local and domestic brands, the effect of domestic tariffs, and trade routes.
Report Coverage
Global Travel Vaccines research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Travel Vaccines report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Travel Vaccines competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Travel Vaccines market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | GSK plc (U.K.), Sanofi (France), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Bavarian Nordic (Denmark), Janssen Pharmaceuticals Inc. (U.S.), CSL Limited (Australia), AstraZeneca (U.K.), Altimmune (U.K.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Crucell (Netherlands) |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Travel Vaccines Market from 2021 to 2031.
- Market Forecast for Travel Vaccines Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Travel Vaccines competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Travel Vaccines
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Travel Vaccines market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Travel Vaccines market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
GSK plc (U.K.), Sanofi (France), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Bavarian Nordic (Denmark), Janssen Pharmaceuticals Inc. (U.S.), CSL Limited (Australia), AstraZeneca (U.K.), Altimmune (U.K.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Crucell (Netherlands)
Primary Target Market
- Market Players of Travel Vaccines
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Travel Vaccines market based on the below-mentioned segments:
Global Travel Vaccines Market, By Composition
Mono vaccines
Combination vaccines
Global Travel Vaccines market, By Application
Outbound travel
Domestic travel
Global Travel Vaccines Market, By Disease Type
Hepatitis A
Hepatitis B
Influenza
Diphtheria pertussis tetanus (DPT)
Rabies
Yellow fever
Typhoid
Measles and mumps
Meningococcal
Other disease vaccines
Global Travel Vaccines market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive travel vaccines market market research and competitor analysis for your business to help you develop more profound insights into the travel vaccines market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the travel vaccines market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.